3/13
08:09 am
abbv
Viokace (AbbVie) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Low
Report
Viokace (AbbVie) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
3/12
08:03 am
abbv
AbbVie (ABBV) had its "buy" rating reaffirmed by Guggenheim.
Low
Report
AbbVie (ABBV) had its "buy" rating reaffirmed by Guggenheim.
3/12
02:43 am
abbv
RBC Capital Says AbbVie Inc. (ABBV) Growth Story Is Still in Early Stages [Yahoo! Finance]
Low
Report
RBC Capital Says AbbVie Inc. (ABBV) Growth Story Is Still in Early Stages [Yahoo! Finance]
3/11
12:43 pm
abbv
Josh Brown: Biotech growth stocks immune to disruption risk [Yahoo! Finance]
Low
Report
Josh Brown: Biotech growth stocks immune to disruption risk [Yahoo! Finance]
3/11
10:21 am
abbv
Market Downturn: 2 Stocks to Buy and Hold Through Any Storm [Yahoo! Finance]
Low
Report
Market Downturn: 2 Stocks to Buy and Hold Through Any Storm [Yahoo! Finance]
3/10
02:18 pm
abbv
AbbVie Inc. (ABBV) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Low
Report
AbbVie Inc. (ABBV) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/10
05:52 am
abbv
Elahere (AbbVie: mirvetuximab soravtansine-gynx) Market Research Report 2026: Epidemiology, Competitive Landscape, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Low
Report
Elahere (AbbVie: mirvetuximab soravtansine-gynx) Market Research Report 2026: Epidemiology, Competitive Landscape, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
3/9
01:06 pm
abbv
AbbVie (ABBV) had its "outperform" rating reaffirmed by William Blair.
Low
Report
AbbVie (ABBV) had its "outperform" rating reaffirmed by William Blair.
3/9
11:05 am
abbv
AbbVie (ABBV) had its "outperform" rating reaffirmed by BMO Capital Markets.
Low
Report
AbbVie (ABBV) had its "outperform" rating reaffirmed by BMO Capital Markets.
3/9
08:10 am
abbv
AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults [Yahoo! Finance]
Low
Report
AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults [Yahoo! Finance]
3/9
08:00 am
abbv
AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults
Low
Report
AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults
3/9
04:59 am
abbv
AbbVie Inc. (ABBV) Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI Subcutaneous Induction in Patients with Crohn's Disease [Yahoo! Finance]
Low
Report
AbbVie Inc. (ABBV) Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI Subcutaneous Induction in Patients with Crohn's Disease [Yahoo! Finance]
3/5
09:20 pm
abbv
???????????????????? : ????????:2035????1856?9000??????????CAGR17.9%???????????????????? [CNET News]
Low
Report
???????????????????? : ????????:2035????1856?9000??????????CAGR17.9%???????????????????? [CNET News]
3/4
09:21 am
abbv
AbbVie: The Only Big Pharma Stock I'd Consider a Buy-and-Never-Sell [Yahoo! Finance]
Low
Report
AbbVie: The Only Big Pharma Stock I'd Consider a Buy-and-Never-Sell [Yahoo! Finance]
3/4
08:00 am
abbv
ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS
Low
Report
ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS
3/3
01:30 pm
abbv
OSE narrows pipeline focus amid Boehringer MASH collaboration retreat [Yahoo! Finance]
Low
Report
OSE narrows pipeline focus amid Boehringer MASH collaboration retreat [Yahoo! Finance]
3/3
08:23 am
abbv
AbbVie to Present at the Leerink Partners Global Healthcare Conference [Yahoo! Finance]
Low
Report
AbbVie to Present at the Leerink Partners Global Healthcare Conference [Yahoo! Finance]
3/3
08:00 am
abbv
AbbVie to Present at the Leerink Partners Global Healthcare Conference
Low
Report
AbbVie to Present at the Leerink Partners Global Healthcare Conference
3/2
08:31 pm
abbv
AbbVie's New Data And Approval Test Growth And Valuation Story [Yahoo! Finance]
Low
Report
AbbVie's New Data And Approval Test Growth And Valuation Story [Yahoo! Finance]
3/2
12:33 pm
abbv
Why AbbVie Stock May Be the Ultimate Option for Dividend Investors [Yahoo! Finance]
Low
Report
Why AbbVie Stock May Be the Ultimate Option for Dividend Investors [Yahoo! Finance]
3/2
08:43 am
abbv
AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease [Yahoo! Finance]
Low
Report
AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease [Yahoo! Finance]
3/2
08:30 am
abbv
AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease
Low
Report
AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease
3/2
03:12 am
abbv
Is AbbVie Inc. (ABBV) One of the Best Cancer Stocks to Invest In Now? [Yahoo! Finance]
Low
Report
Is AbbVie Inc. (ABBV) One of the Best Cancer Stocks to Invest In Now? [Yahoo! Finance]
2/26
03:45 pm
abbv
Where Will AbbVie Be in 5 Years? [Yahoo! Finance]
Low
Report
Where Will AbbVie Be in 5 Years? [Yahoo! Finance]
2/26
07:35 am
abbv
Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVie [Seeking Alpha]
Low
Report
Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVie [Seeking Alpha]